PDS Biotechnology Corporation
PDSB
$0.82
$0.056.44%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 16.01% | -13.28% | 19.94% | 27.03% | 1.13% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 4.86% | 4.86% | 4.86% |
| Total Amortization of Deferred Charges | -200.69% | 292.53% | 0.89% | 14.49% | 92.61% |
| Total Other Non-Cash Items | 12.43% | -78.28% | -10.59% | -6.89% | -15.87% |
| Change in Net Operating Assets | 120.58% | 56.98% | -83.16% | -658.82% | -54.68% |
| Cash from Operations | 26.05% | -2.75% | 9.12% | 2.63% | -11.48% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7,102.13% | -142,672.46% | -23,157.78% | -23,683.33% | -9.30% |
| Issuance of Common Stock | 3,915.02% | -- | -63.54% | -69.27% | -96.16% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,302.33% | 7,316.67% | -63.42% | -98.39% | -97.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.91% | 8.94% | -116.98% | -449.13% | -25.24% |